147 related articles for article (PubMed ID: 6179768)
1. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the cytosol androgen receptor of the human prostate.
Wilbert DM; Griffin JE; Wilson JD
J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
[TBL] [Abstract][Full Text] [Related]
3. Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
Akimoto S; Fuse H; Sato R; Zama S; Shimazaki J
Endocrinol Jpn; 1985 Feb; 32(1):141-52. PubMed ID: 2410244
[TBL] [Abstract][Full Text] [Related]
4. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
[TBL] [Abstract][Full Text] [Related]
5. Androgen stimulated elevation in androgen receptor levels is inhibited by the synthetic glucocorticoid triamcinolone acetonide.
Syms AJ; Norris JS; Smith RG
Biochem Biophys Res Commun; 1983 Nov; 116(3):1020-5. PubMed ID: 6606427
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
Murthy LR; Chang CH; Rowley DR; Scardino PT; Tindall DJ
Prostate; 1984; 5(6):567-79. PubMed ID: 6208540
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.
Shain SA; Boesel RW; Lamm DL; Radwin HM
J Clin Endocrinol Metab; 1980 Apr; 50(4):704-11. PubMed ID: 6154061
[No Abstract] [Full Text] [Related]
8. Binding of [3H]methyltrienolone to androgen receptor in rat liver.
Kyakumoto S; Sato N; Nemoto T; Ohara-Nemoto Y; Ota M
Biochim Biophys Acta; 1984 Aug; 800(3):214-9. PubMed ID: 6331850
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).
Asselin J; Mélançon R; Gourdeau Y; Labrie F; Bonne C; Raynaud JP
J Steroid Biochem; 1979 May; 10(5):483-6. PubMed ID: 88546
[No Abstract] [Full Text] [Related]
11. Androgen receptor content of normal and hyperplastic human prostate.
Trachtenberg J; Bujnovszky P; Walsh PC
J Clin Endocrinol Metab; 1982 Jan; 54(1):17-21. PubMed ID: 6172440
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight component of androgen receptor in cytosols from benign hypertrophic human prostate treated with high KCl solution.
Kodama T; Fuse H; Shimazaki J
Endocrinol Jpn; 1982 Jun; 29(3):325-33. PubMed ID: 6184218
[TBL] [Abstract][Full Text] [Related]
13. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
[No Abstract] [Full Text] [Related]
14. Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?
Mobbs BG; Johnson IE; Connolly JG; Thompson J
J Steroid Biochem; 1983 Sep; 19(3):1279-90. PubMed ID: 6604842
[TBL] [Abstract][Full Text] [Related]
15. Properties of progestin-binding protein in benign hypertrophic human prostate.
Akimoto S; Sato R; Kodama T; Zama S; Fuse H; Shimazaki J
Endocrinol Jpn; 1986 Jun; 33(3):423-32. PubMed ID: 2428606
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of androgen receptor by nonandrogenic steroids.
Nemoto T; Ohara-Nemoto Y; Sato M; Ota M
Biochem Int; 1986 May; 12(5):701-5. PubMed ID: 3488063
[TBL] [Abstract][Full Text] [Related]
17. A hybrid ligand method for androgen receptor measurement.
Stebbings WS; Anderson E; Puddefoot JR; Farthing MJ; Vinson GP
J Steroid Biochem; 1988 Aug; 31(2):181-6. PubMed ID: 2457134
[TBL] [Abstract][Full Text] [Related]
18. Receptor proteins for androgens in prostatic disease.
Ghanadian R; Auf G; Chisholm GD; O'Donoghue EP
Br J Urol; 1978 Dec; 50(7):567-9. PubMed ID: 88985
[TBL] [Abstract][Full Text] [Related]
19. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the binding nature of mibolerone to androgen receptor of human prostate with that of R1881].
Miki H; Oshimo K; Inoue H; Sumi T; Yamashita K; Morimoto T; Monden Y
Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):655-65. PubMed ID: 3265669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
